Catalyst Wire Dossier Catalyst Wire Dossier

Osurnia

florfenicol and terbinafine ophthalmic suspension · Meda Pharmaceuticals (now part of Elanco) / Dechra? (Note: Osurnia is marketed by Elanco Animal Health)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Osurnia, covering 2018-04-20 to 2018-04-20. Get the full timeline:

Most recent: Eye injuries in people and dogs when using Osurnia ear gel for dogs

See pricing